Candida auris has developed the ability to survive on cool external skin and cold inorganic surfaces, allowing it to linger on the hands of healthcare workers and on the doorknobs and counters and computer keys of a hospital room. It can travel from its original host to new victims, passing from person to person in outbreaks that last for weeks or months.
A virulent strain of Klebsiella pneumoniae that is resistant to carbapenem and colistin has been isolated for the first time from a patient in the US.
An epidemic of extensively drug-resistant typhoid is spreading through Pakistan, infecting a minimum of 850 people in 14 districts.
Candida auris’ potential to cause multidrug-resistant outbreaks and the lack of laboratory capacities in many countries to detect the pathogen render it a public health threat.
Researchers report the genomic characterization of an unusual Klebsiella pneumoniae, nonsusceptible to all 26 antibiotics tested, that was isolated from a US patient.
The US Centers for Disease Control and Prevention (CDC) researchers reported that more than 1,400 isolates of carbapenemase-producing bacteria were identified from clinical samples from 32 states during the first nine months of 2017.
The increasing incidence of multi-drug resistant organism infections has become a safety concern for patients across the continuum of patient care.
Azithromycin resistance in a S. Typhi pathogen would return developing countries to a pre-1948 scenario in which 15 percent of cases of typhoid fever end in fatality.
The guidance provides more than 100 recommendations on appropriate treatment for multidrug resistant (MDR) gram-negative bacterial (GNB) infections.